Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs. Draeger Teresa et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Sep 23(9) 1149-1156

Main|Search|PHGKB




Last Posted: Sep 24, 2020

---

• Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs.
  Draeger Teresa et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Sep 23(9) 1149-1156
• Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.
  Kapoor Ritika et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Sep 23(9) 1171-1179
• A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature.
  Ten Ham Renske M T et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Sep 23(9) 1268-1280
• Ethical Questions Concerning Newborn Genetic Screening.
  Esquerda Montse et al. Clinical genetics 2020 Aug
• HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies.
  Coyle Doug et al. The European journal of health economics : HEPAC : health economics in prevention and care 2020 Aug
• Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments.
  Coquerelle Séverine et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Jul 23(7) 898-906
• Costs of in-house genomic profiling and implications for economic evaluation: A case example of non-small cell lung cancer (NSCLC).
  Johnston Karissa M et al. Journal of medical economics 2020 Jun 1
• Using machine learning to assess the predictive potential of standardized nursing data for home healthcare case-mix classification.
  de Korte Maud H et al. The European journal of health economics : HEPAC : health economics in prevention and care 2020 Jun
• Economic value of exome sequencing for suspected monogenic disorders
  BS Ferket et al, Genetics in Medicine, June 30, 2020
• Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer.
  Simoes Correa-Galendi Julia et al. Applied health economics and health policy 2020 Jun

more